MetaMe Health

MetaMe Health, founded in 2016, focuses on developing hypnotherapy for Irritable Bowel Syndrome (IBS). Severe IBS has been shown to potentially trigger mental health disorders such as depression or anxiety. Existing drug therapies are generally limited to specific patients and often come with potential side effects. The company aims to develop Regulura, a digital hypnotherapy for IBS that meets FDA standards, to become the first FDA-approved prescription digital therapeutic for treating Irritable Bowel Syndrome (IBS). More than 30 million Americans suffer from IBS and its associated symptoms like abdominal pain, diarrhea, or constipation. Regulora™ for IBS alleviates pain by digitizing the standardized Brain-Gut treatment method, which has been clinically proven to effectively reduce IBS symptoms.